Director of Clinical operations, Division of General and Oncologic Surgery University of Maryland School of Medicine Greenabaum Cancer Center, Director of Cancer Institute, University of Maryland St. Joseph Medical Center
General Surgery
Nader N. Hanna, MB
|
|
Give Review
Nader Hanna works in the field of General Surgery. He has 11 awards "America's Top Doctors for Cancer", "Top Doctors:Baltimore Area", "Top Doctors (Top 1%)", "Humanitarian Award Recipient", "Abraham Flexner Master Educator Award for Outstanding Teaching Contribution/Mentorship", "James Ewing Basic Science Research Award", "Award for Surgical Research in Basic Science", "America's Top Doctors", "Top Doctors:Washington-Baltimore", "Super Doctor" and "Fellow (FACS)". Nader N. Hanna, MB has written publications. He has 54 publications published with PubMed. The lastest paper is: 'Advances in the pathogenesis and treatment of thyroid cancer.' He is registered with Medicare.
Publications
- The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base.
- Effectiveness of an antimicrobial polymer to decrease contamination of environmental surfaces in the clinical setting.
- Cost-Effectiveness of Second-Line Chemotherapy/Biologics among Elderly Metastatic Colon Cancer Patients.
- Comparative and Cost Effectiveness of Treatment Modalities for Hepatocellular Carcinoma in SEER-Medicare.
- FOXL1, a Novel Candidate Tumor Suppressor, Inhibits Tumor Aggressiveness and Predicts Outcome in Human Pancreatic Cancer.
- Multispecialist Care and Mortality in Hepatocellular Carcinoma.
- Tumour antigen targeted monoclonal antibodies incorporating a novel multimerisation domain significantly enhance antibody dependent cellular cytotoxicity against colon...
- Hospital Center Effect for Laparoscopic Colectomy Among Elderly Stage I-III Colon Cancer Patients.
- Multidisciplinary physician care and mortality in hepatocellular Carcinoma.
- Association between overall incremental cost and survival benefit of second line chemotherapy/biologics treatment among elderly medicare metastatic colon Cancer patients.
- Treatment modalities for hepatocellular Carcinoma: cumulative expenditures and survival in seer-medicare.
- The use of transarterial chemoembolization for treating hepatocellular Carcinoma in the seer-medicare population.
- Algorithm for Identifying Chemotherapy/Biological Regimens for Metastatic Colon Cancer in SEER-Medicare.
- Assessment of neoadjuvant chemotherapy on operative parameters and outcome in patients with peritoneal dissemination from high-grade appendiceal Cancer.
- Treatment factors associated with long-term survival after cytoreDuctive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma.
- Assessment of clinical benefit and quality of life in patients undergoing cytoreDuction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for management of periton...
- Impact of Venous Thromboembolism on Mortality of Elderly Medicare Patients with Stage III Colon Cancer.
- Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic c...
- Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon canc...
- Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenoCarcinoma.
- Comparative Effectiveness of Different Chemotherapeutic Regimens on Survival of People Aged 66 and Older with Stage III Colon Cancer: A 'Real World' Analysis Using Sur...
- Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon Cancer patients over 65 years: an analysis using Sur...
- Palliative surgical oncology.
- ZIP14 Zinc Transporter Downregulation and Zinc Depletion in the Development and Progression of Hepatocellular Cancer.
- ACS-NSQIP criteria are associated with APACHE severity and outcomes in critically ill surgical patients.
- Intensity-modulated radiation therapy significantly improves acute gastrointestinal toxicity in pancreatic and ampullary Cancers.
- Trends in disparities in receipt of adjuvant therapy for elderly stage III colon Cancer patients: the role of the medical oncologist evaluation.
- Presacral schwannoma diagnosed by EUS-guided FNA.
- Composite signet-ring cell/neuroendocrine Carcinoma of the stomach with a metastatic neuroendocrine Carcinoma component: a better prognosis entity.
- Low-dose radiotherapy as a chemopotentiator of gemcitabine in tumors of the pancreas or small bowel: a phase I study exploring a new treatment paradigm.
- Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal Cancer: Radiation Therapy Oncology Group Trial 0012.
- Is there a role for palliative gastrectomy in patients with stage IV gastric Cancer?
- Cancer caregiving and subjective stress: a multi-site, multi-dimensional analysis.
- A Phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremities.
- Radiofrequency ablation of primary and metastatic hepatic malignancies.
- TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors.
- Ovarian neoplasms in patients with colorectal Cancer: understanding the role of prophylactic oophorectomy.
- Molecular genetics and management strategies in hereditary Cancer syndromes.
- Dual inDuction of the Epo-Egr-TNF-alpha- plasmid in hypoxic human colon adenocarcinoma produces tumor growth delay.
- Intraoperative parasympathetic nerve stimulation with tumescence monitoring during total mesorectal excision for rectal Cancer.
- Transarterial Chemoembolization Treatment: Association between Multiple Treatments, Cumulative Expenditures, and Survival.
- Advances in the pathogenesis and treatment of thyroid Cancer.
- Advances in the management of Adrenal tumors.
- Development of a research agenda for the management of metastatic colorectal Cancer: proceedings from a multidisciplinary research consensus panel.
- Hypertension in patients with pheochromocytoma.
- DPEP1 Inhibits Tumor Cell Invasiveness, Enhances Chemosensitivity and Predicts Clinical Outcome in Pancreatic Ductal Adenocarcinoma.
- Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human Cancer xenografts.
- Antitumor interaction of short-course endostatin and ionizing radiation.
- Combined effects of angiostatin and ionizing radiation in antitumour therapy.
- Spatial and temporal control of gene therapy using ionizing radiation.
- EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic Cancer: a phas...
- Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature.
- Radiation-inducible gene therapy.
Schools
University of Ain Shams Faculty of Medicine
Waltham Weston Hospital
St Elizabeth39s Med CtrTufts University
University of Chicago
Procedures Preformed
- Adrenalectomy
- Appendectomy, Laparoscopic
- Appendectomy, Open
- Colectomy
- View All
Conditions Treated
- Abdominal Pain
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anal Fissure
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Awards
- America's Top Doctors for Cancer
- Top Doctors:Baltimore Area
- Top Doctors (Top 1%)
- Humanitarian Award Recipient
- Abraham Flexner Master Educator Award for Outstanding Teaching Contribution/Mentorship
- James Ewing Basic Science Research Award
- Award for Surgical Research in Basic Science
- America's Top Doctors
- Top Doctors:Washington-Baltimore
- Super Doctor
- Fellow (FACS)
Education
-
University of Chicago -
St Elizabeth's Medical Center -
Ain Shams University Faculty of Medicine
Hospital
-
University of Maryland St. Joseph Medical Center -
University of Maryland Medical Center
Drug Facts
| NPI NUMBER | 1366466542 | |
| NPPES Provider LastName | HANNA | |
| NPPES Provider FirstName | NADER | |
| NPPES Provider ZIPCode | 212011544 | |
| NPPES Provider State | MD | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 11.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1366466542 |
| Last Name Of The Provider | HANNA |
| First Name Of The Provider | NADER |
| View All |
Similar Doctors
|
|
Dr. Richard Schulick, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas Genuit, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William H. Bouchelle, MD |
|
|
Dr. Jeannie Y. Chun, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ghaleb A. Darwazeh, MD |
|
|
Dr. Peter L. Dixon, MD |
|
|
Dr. Devin M. O'Brien-Coon, MD |
|
|
Dr. Zain Shahid, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charlotte L. Kvasnovsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Siamak Dahi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Daniel Mansour
This Doctor is OpenDoctor Recommended.
|